Our Promise to you:
Premier global microbiological solutions, extensive collection of products.
24x7 CUSTOMER SERVICE
CONTACT US TO ORDER
Lymphomas are a group of tumors that begins in infection-fighting cells of the immune system, called lymphocytes. Treatment for lymphomas has advanced significantly as multiple novel targeted therapy approaches have been developed. Targeted therapy has the potential to be a highly effective therapy with more precisely and lower toxicity.
|Target||Types||Agent||Manufacturer||Start Marketing Date|
|26S proteasome||Small molecule||Velcade||Millenlum||2003|
In the field of cancer treatment, it was observed that the bacteria have the ability to deliver tumor-specific anticancer genes and the potential tumor-targeting antitumor capability.
As a leader in oncolytic bacteria genome editing, Creative Biogene provides a "one-stop shop" tailored to your gene research needs. We have expertise in gene knockout, knock-in/replacement and site-directed mutagenesis. Creative Biogene is able to provide you the comprehensive oncolytic bacteria genome editing service, including traditional recombineering system, CRISPR/Cas 9 system and site-specific recombination system.
Creative Biogene is dedicated to providing Complete Solutions for oncolytic bacteria genome editing to help you every step of the way in your genome editing workflow. And we offer full-service for genetic modification which has been successfully achieved in microorganisms, such as E. coli, Salmonella, Streptomyces, Clostridium, Bacillus subtilis, Saccharomyces cerevisiae, filamentous fungi, and so on. Simply let us know how you want the genome to be edited. We will propose the best strategy for you.
1. Yuan, M., Huang, L., Chen, J. et al. The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Sig Transduct Target Ther 4, 61 (2019).
2. Dougan, M., & Dougan, S. K. (2019). Programmable bacteria as cancer therapy. Nature Medicine.